Biocaptiva

CfDNA capture polymers and a whole-blood extraction kit for labs working on liquid biopsy and personalised medicine

Edinburgh, United KingdomFounded 2018biocaptiva.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-30

About Biocaptiva

Biocaptiva develops msX™, a suite of patented polymers that capture cell-free DNA (cfDNA) directly from biological fluids such as plasma, whole blood, urine and pleural effusion, without additional binding reagents. The polymers can be coated onto beads, foams or solid surfaces. The msX-B™ whole blood cfDNA kit is designed for magnetic bead workflows and can be automated on particle mover or liquid handler platforms.

The company's customers are laboratories and developers working on liquid biopsy, cfDNA sequencing and personalised treatment. It offers the msX-B™ kit and polymer coatings tailored to specific applications and biological fluids. The polymers are produced under an ISO 13485 compliant quality management system.

Biocaptiva was founded in 2018 and is headquartered in Edinburgh, United Kingdom. It spun out of the University of Edinburgh in 2021. The company lists a board including a CEO, a non-executive chairman, an investor director and a CFO, and plans to exhibit at LSI Europe '26 in Barcelona from 28 September to 1 October 2026.

Product: msX™ cfDNA-capturing polymers, including the msX-B™ whole blood cfDNA extraction kit.

Jobs at Biocaptiva

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Biomodal

    Sequencing kits that read genetic variants and methylation from the same DNA sample for life science researchers
    Saffron Walden, United KingdomBiotech & pharmaFounded 2012
    New on Evolc
  • Biorelate

    Literature-mined cause-and-effect data linking drugs, genes and diseases, for drug discovery and bioinformatics teams
    Manchester, United KingdomBiotech & pharmaFounded 20142 open jobs
    New on EvolcRemote-friendly
  • Biorex Diagnostics

    In vitro diagnostic tests and reagents for hospitals, clinics, blood banks and research facilities
    Antrim, United KingdomBiotech & pharmaFounded 2003
    New on Evolc
  • Blue Earth Diagnostics

    Develops and commercialises PET molecular imaging agents for cancer and cardiology, used by clinicians and patients
    Oxford, United KingdomBiotech & pharmaFounded 201330 open jobs
    New on EvolcSalary transparent
  • Blue Earth Therapeutics

    Clinical-stage radiopharmaceutical developer targeting prostate cancer with PSMA-targeted radiohybrid therapies
    Oxford, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Bounce Biomedical

    Develops regenerative implants for patients with cartilage and bone injuries in joints
    Abingdon, United KingdomBiotech & pharmaFounded 2008
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Squarespace